Cleary Gottlieb Steen & Hamilton and Goodwin Procter are advising on Tokyo-based Takeda Pharmaceutical's $6 billion acquisition of Nimbus Lakshmi, a wholly-owned subsidiary of U.S.-based clinical-stage, structure-based drug discovery company Nimbus Therapeutics.